Exposing drug industry funding of UK patient organisations.
Where this comes from
- Record sourced from PubMed, PMID 31122928.
- Also identified by DOI 10.1136/bmj.l1806 and PMC identifier 6529850.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Drug company payment disclosures have limited transparency, but <b>Piotr Ozieranski and colleagues</b> find that they are increasing in value and are targeted at select patient organisations
Medical subject headings
- Drug Industry
- Financial Support
- Voluntary Health Agencies